Ionis Pharmaceuticals IONS Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Compensation Percent
Effective Income Tax Rate Reconciliation Nondeductible Expense Excess Compensation Percent at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessCompensationPercent.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's effective income tax rate reconciliation nondeductible expense excess compensation percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's effective income tax rate reconciliation nondeductible expense excess compensation percent?
- Ionis Pharmaceuticals (IONS) reported effective income tax rate reconciliation nondeductible expense excess compensation percent of -0.4% in Q4 2024.
- What does effective income tax rate reconciliation nondeductible expense excess compensation percent mean?
- The percentage increase in the effective tax rate due to non-deductible compensation.
- How do you interpret effective income tax rate reconciliation nondeductible expense excess compensation percent?
- A lower percentage is preferred as it indicates better tax alignment of compensation structures.
- How does effective income tax rate reconciliation nondeductible expense excess compensation percent compare across companies?
- Used to benchmark tax-efficient compensation strategies against industry peers.